Fapon

Fapon is a prominent global provider of in vitro diagnostic (IVD) solutions, specializing in the development of high-performance raw materials, reagent solutions, and open instrument platforms. Established in 2001 and headquartered in Dongguan, China, the company supports a vast network of IVD manufacturers and clinical laboratories with a portfolio of over 1,000 reagents, including antigens, antibodies, and enzymes. Fapon has significantly expanded its footprint into the biopharmaceutical sector through its subsidiary, Fapon Biopharma, which focuses on innovative therapeutic antibodies and cell therapies for oncology and immunology. The company gained international recognition for its rapid development of COVID-19 diagnostic components, underscoring its robust R&D and manufacturing capabilities. By integrating diagnostic and therapeutic expertise, Fapon aims to drive the evolution of precision medicine and improve global healthcare outcomes.